| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1928723 | Biochemical and Biophysical Research Communications | 2013 | 6 Pages |
Pancreas cancer, is the fourth leading cause of cancer death but its cell of origin is controversial. We compared the localization of stem cells in normal and cancerous pancreas using antibodies to the stem cell markers Nanog and LGR5. Here we show, for the first time, that LGR5 is expressed in normal pancreas, exclusively in the islets of Langerhans and it is co-localized, surprisingly, with Nanog and insulin in clusters of beta cells. In cancerous pancreas Nanog and LGR5 are expressed in the remaining islets and in all ductal cancer cells. We observed insulin staining among the ductal cancer cells, but not in metastases. This indicates that the islet’s beta cells, expressing LGR5 and Nanog markers are the initiating cells of pancreas cancer, which migrated from the islets to form the ductal cancerous tissue, probably after mutation and de-differentiation. This discovery may facilitate treatment of this devastating cancer.
► Identification of beta cells as pancreatic tissue stem cells. ► Pancreatic stem cells as a potential of cancer stem cells. ► LGR5 and Nanog as markers of pancreatic stem cells.
